Assessment of microvascular function and pharmacological regulation in genetically confirmed familial hypercholesterolemia
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Microvascular Research
- Vol. 138, 104216
Abstract
No abstract availableKeywords
Funding Information
- Ministerstwo Edukacji i Nauki (POIR.01.01.01-00-0540/15)
- European Regional Development Fund (POIR.01.01.01-00-0540/15)
- European Commission (POIR.01.01.01-00-0540/15)
This publication has 41 references indexed in Scilit:
- Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humansThe Journal of Physiology, 2011
- Pleiotropic Effects of StatinsAmerican Journal of Cardiovascular Drugs, 2010
- Mitochondrial Dysfunction in AtherosclerosisCirculation Research, 2007
- Mitochondrial function in vivo evaluated by NADH fluorescence: from animal models to human studiesAmerican Journal of Physiology-Cell Physiology, 2007
- Mitochondrial dysfunction in cardiovascular diseaseFree Radical Biology and Medicine, 2005
- Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patientsJACC, 2003
- Circulating Oxidized Low Density Lipoprotein LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.Journal of Clinical Investigation, 1994
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- PRENATAL DIAGNOSIS OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLqMIA Expression of a Genetic Receptor Disease in UteroThe Lancet, 1978